Your browser doesn't support javascript.
loading
Identification of a novel fusion gene HMGA2-EGFR in glioblastoma.
Komuro, Akiyoshi; Raja, Erna; Iwata, Caname; Soda, Manabu; Isogaya, Kazunobu; Yuki, Keiko; Ino, Yasushi; Morikawa, Masato; Todo, Tomoki; Aburatani, Hiroyuki; Suzuki, Hiromichi; Ranjit, Melissa; Natsume, Atsushi; Mukasa, Akitake; Saito, Nobuhito; Okada, Hitoshi; Mano, Hiroyuki; Miyazono, Kohei; Koinuma, Daizo.
Afiliação
  • Komuro A; Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Raja E; Department of Biochemistry, Kindai University Faculty of Medicine, Osaka, Japan.
  • Iwata C; Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Soda M; Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Isogaya K; Department of Cellular Signaling, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Yuki K; Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Ino Y; Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Morikawa M; Division of Innovative Cancer Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Todo T; Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Aburatani H; Division of Innovative Cancer Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Suzuki H; Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
  • Ranjit M; Department of Neurosurgery, Graduate School of Medicine, Nagoya University, Nagoya, Japan.
  • Natsume A; Department of Neurosurgery, Graduate School of Medicine, Nagoya University, Nagoya, Japan.
  • Mukasa A; Department of Neurosurgery, Graduate School of Medicine, Nagoya University, Nagoya, Japan.
  • Saito N; Department of Neurosurgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Okada H; Department of Neurosurgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Mano H; Department of Biochemistry, Kindai University Faculty of Medicine, Osaka, Japan.
  • Miyazono K; Department of Cellular Signaling, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Koinuma D; Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Int J Cancer ; 142(8): 1627-1639, 2018 04 15.
Article em En | MEDLINE | ID: mdl-29193056
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas de Fusão Oncogênica / Glioblastoma / Proteína HMGA2 / Receptores ErbB Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas de Fusão Oncogênica / Glioblastoma / Proteína HMGA2 / Receptores ErbB Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article